Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024BJPsych OpenOpen Access

Consideration of Clozapine in Patients With Treatment Resistant Schizophrenia

View Full Paper
Ask AI
Bookmark
Share

Authors

NMNiema MoazzamiBradford District Care NHS Foundation TrustADAimee DevereuxBradford District Care NHS Foundation Trust

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Moazzami et al. (2024) studied this question.

synapsesocial.com/papers/68e674ddb6db6435875ff70fhttps://doi.org/10.1192/bjo.2024.603
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Community Clozapine Initiation Practice2024
  2. 2Clozapine response in patients with treatment-resistant schizophrenia: a preliminary report2025
  3. 3Evaluation of major adverse events of clozapine based on accordance to an international titration guideline2024 · 2 citations
  4. 4Management of clozapine-resistant schizophrenia2026
  5. 5Delay in Clozapine Initiation in Patients with Treatment-Resistance Schizophrenia Presenting Tertiary Psychiatric Facilities2024 · 1 citations